We work together with hospitals in Germany, the Netherlands and Switzerland. They provide us directly with cancer samples form consenting patients
Highly skilled experts in microfluidic technology and personalized medicine The strength of TheraME! is its team's multidisciplinary expertise.
TheraME! has gained the support of renowned partners. In 2018, The potential of our technology for both, clinical applicability and commercialization has been recognized by the German Ministry of Economy and Energy. In a highly competitive call, our approach has been awarded with an EXIST grant. In 2020, we have been awarded with a prestigious Innosuisse grant of the Swiss Innovation Agency and in 2021 we received large funding through the PHRT strategic focus area of the ETH Domain.